Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
BioPharma Dive
7h
After rejections, AbbVie secures approval for Parkinson’s drug
Vyalev’s clearance is the second victory for AbbVie in Parkinson’s this year, following an April readout for a drug acquired through its Cerevel buyout.
BioPharma Dive
8h
Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe
The deal offers Lexicon a cash infusion of $25 million as the company tries to broaden use of the heart failure and diabetes medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Hamas leader Sinwar killed
Preliminary cause of death
Panel calls for 'reform'
Charged with theft
Fox News interview
100-yr-old capsule unveiled
Sentenced for cartel bribery
NH justice indicted
‘South Pacific' star dies
DA aims to revive charges
Capitol rioter pleads guilty
Microscopic world photos
Meta confirms layoffs
AL voter roll purge blocked
May help with addiction too
US strikes Houthi targets
Teacher re-enacted murder
$425M military aid for UKR
GA election rules blocked
Holds meeting on Gaza aid
US jobless claims fall
21K+ SUVs recalled
Mutual HIV transplants safe
Allows EPA emissions rule
Antisemitic billboard hack
More loan forgiveness
Says AI prevented fraud
Feedback